Articles dans des revues avec comité de lecture (51)
46.
Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., Kiss, R., & Amighi, K. (2010). Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment. Pharmaceutical research, 28(4), 762-75. doi:10.1007/s11095-010-0329-x47.
Lamoral-Theys, D., Pottier, L., Kerff, F., Dufrasne, F., Proutiere, F., Wauthoz, N., Neven, P., Ingrassia, L., Van Antwerpen, P., Lefranc, F., Gelbcke, M., Pirotte, B., Kraus, J.-L., Neve, J., Kornienko, A., Kiss, R., & Dubois, J. (2010). Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli. Bioorganic & medicinal chemistry, 18(11), 3823-3833. doi:10.1016/j.bmc.2010.04.04748.
Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2010). In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. European journal of pharmaceutical sciences, 39, 402-411. doi:10.1016/j.ejps.2010.01.01049.
Lamoral-Theys, D., Andolfi, A., Van Goietsenoven, G., Cimmino, A., Le Calve, B., Wauthoz, N., Megalizzi, V., Gras, T., Bruyère, C., Dubois, J., Mathieu, V., Kornienko, A., Kiss, R., & Evidente, A. (2009). Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. Journal of medicinal chemistry, 52(20), 6244-6256. doi:10.1021/jm901031h50.
Charlier, N., Driesschaert, B., Wauthoz, N., Beghein, N., Préat, V., Amighi, K., Marchand-Brynaert, J., & Gallez, B. (2009). Nano-emulsions of fluorinated trityl radicals as sensors for EPR oximetry. Journal of magnetic resonance, 197(2), 176-180. doi:10.1016/j.jmr.2008.12.01351.
Wauthoz, N., Balde, A., Balde, E. S., Van Damme, M., & Duez, P. (2007). Ethnopharmacology of Mangifera indica L. Bark and Pharmacological Studies of its Main C-Gucosylxanthone, Mangiferin. International Journal of Biomedical and Pharmaceutical Sciences, 1(2), 112-119. Communications publiées lors de congrès ou colloques nationaux et internationaux (19)
1.
Wauthoz, N., Chraibi, S., Davenne, T., Gerard, P., Rosiere, R., & Amighi, K. (2023). Evaluation of Tumour Exposure following the Administration of an Innovative Cisplatin Dry Powder for Inhalation at Different Dose Levels and Regimens. Journal of Aerosol Medicine and Pulmonary Drug Delivery.2.
Menchi, E., El Khattabi, C., Denis, O., Pochet, S., Amighi, K., & Wauthoz, N. (2022). Determination of an appropriate dose ratio of a synergistic combination of long-acting bronchodilators for the maintenance treatment of asthma and COPD. Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 35(35), A1-A20 , 1-20. doi:10.1089/jamp.2022.ab01.abstracts3.
Ravon, F., Menchi, E., Remmelink, M., Chraibi, S., Fontaine, V., & Wauthoz, N. (2022). In vitro and in vivo evaluations of the tolerance of a new and innovative anti-tuberculosis drug combination by inhalation. Abstracts from The Aerosol Society Drug Delivery to the Lungs 32. Vol. 35(35), A1-A20 (pp. 1-20) Drug Delivery to the Lungs(32: 8-10th December: Virtual). doi:10.1089/jamp.2022.ab01.abstracts4.
Chraibi, S., Spires, J. J., Amighi, K., & Wauthoz, N. (2019). In silico Prediction of Pharmacokinetic Parameters after Cisplatin Intravenous and Endotracheal Administration Using GastroPlus TM Software. Journal of Aerosol Medicine and Pulmonary Drug Delivery,(32), 2 , 28-30. doi:10.1089/jamp.2019.ab01.abstracts